CDSCO License for Transvenous phrenic nerve electrical stimulation control unit
Medical Device Information
Intended Use
Intended to configure/deliver stimulation of the phrenic nerve, via a transvenous electrode, to cause contraction of the diaphragm in conjunction with mechanical ventilation to assist earlier ventilation weaning.

Comprehensive Guide to CDSCO Licensing for Transvenous Phrenic Nerve Electrical Stimulation Control Unit (Class D Device)
As a trusted regulatory consultancy with over 25 years of experience and more than 500 successful CDSCO license approvals, we understand the challenges that manufacturers and importers face when entering the Indian medical device market. This guide focuses specifically on the Transvenous Phrenic Nerve Electrical Stimulation Control Unit—a Class D neurological device designed to assist earlier ventilation weaning by stimulating the diaphragm via the phrenic nerve.
Understanding the Device and Regulatory Importance
The Transvenous Phrenic Nerve Electrical Stimulation Control Unit is a critical neurological device that works in conjunction with mechanical ventilators. Given its complex function and direct impact on patient respiratory function, it is classified as a high-risk Class D medical device under the CDSCO framework. Regulatory compliance is not only mandatory but essential for patient safety and market access in India.
CDSCO Regulatory Framework for Class D Neurological Devices
Class D devices like this control unit fall under the highest risk category as per the CDSCO’s Medical Device Rules, 2017. Consequently, licensing is governed centrally by the CDSCO, and the device must meet stringent requirements including product testing, quality management systems, and audits.
For the Transvenous Phrenic Nerve Electrical Stimulation Control Unit, the applicable license is the MD9 Manufacturing License if manufactured domestically or the MD15 Import License if imported.
Risk Classification and License Requirements
- Risk Class: D (highest risk)
- License Type: MD9 for manufacturing, MD15 for import
- Regulatory Authority: Central Licensing Authority, CDSCO
- Notification Reference: 29/Misc/03/2020-DC (201), dated 27.09.2021
You can verify device classification and official notifications on the Medical Device Classification portal.
Manufacturing License Process (MD9) for Class D Devices
The MD9 license is mandatory for manufacturing Class D devices like the Transvenous Phrenic Nerve Electrical Stimulation Control Unit. Here’s the stepwise process:
- Apply for Test License (Form MD13): The first step involves obtaining a Test License to allow product testing. This step typically takes 1.5 to 2 months.
- Product Testing: Testing must be conducted at CDSCO-approved labs. Refer to the list of government-approved testing laboratories for selection.
- Document Preparation: Compile all required technical and quality documents.
- Application for Manufacturing License (Form MD7): Submit your MD9 license application through the CDSCO MD Online Portal.
- Audit by CDSCO Inspectors: CDSCO will conduct a thorough audit of your manufacturing facility.
- Resolution of Queries: Address any queries or deficiencies raised by the department or auditors.
- Grant of License (Form MD9): Upon successful compliance, the license is issued.
Manufacturing License Documents Required for MD9
Manufacturers must prepare and submit the following key documents:
- Company Constitution and Incorporation Documents
- Proof of Ownership or Lease of Manufacturing Premises
- Technical Staff Qualification and Experience Certificates
- Plant Master File: Document describing your manufacturing site and processes. Our detailed Plant Master File guide can help streamline this.
- Device Master File: Comprehensive technical documentation about the device’s design, development, and manufacturing. Learn more in our Device Master File guide.
- Essential Principles Checklist confirming compliance with Indian regulations
- Risk Management File: Documented risk analysis and mitigation strategies per ISO 14971. Visit our Risk Management resource for practical insights.
- Test Reports from CDSCO-approved labs
- Labels and Instructions for Use (IFU)
- Quality Management System (QMS) Documents: ISO 13485:2016 certification and associated procedures
- Fire and Pollution NOCs from relevant authorities
Import License Process (MD15) for Class D Devices
For importers, the MD15 license issued by the CDSCO Central Licensing Authority is required. The process is slightly different as it does not require a test license but does demand comprehensive documentation:
- Document Preparation: Collect all required technical and regulatory documents.
- Submission of Application (Form MD14): File your import license application via the CDSCO MD Online Portal.
- Queries and Clarifications: Respond promptly to any CDSCO queries.
- License Grant (Form MD15): Upon successful review, the import license is granted.
Import License Documents Required
- Valid Manufacturing License from Country of Origin
- Free Sale Certificate and Certificate of ISO 13485:2016
- CE Certificate or equivalent international approvals
- Device Master File and Plant Master File
- Wholesale License for distribution in India
- Company Constitution and Importer Details
Timeline and Processing Duration
License Type | Process Steps | Approximate Duration |
---|---|---|
MD9 Manufacturing License | Test license (MD13), product testing, application, audit, queries resolution | 4 to 5 months total |
MD15 Import License | Document submission, queries resolution, license grant | 5 to 6 months |
Note: Delays often occur during audit scheduling or document clarifications. Early preparation and expert support can reduce turnaround time.
Government Fees and Costs
- MD9 Manufacturing License:
- Application Fee: ₹50,000
- Per Product Fee: ₹1,000
- MD15 Import License:
- Class D devices: $3,000 per site
- Per Product Fee: $1,500
These fees are payable through the CDSCO portal. Budget also for audit fees, testing charges, and consultancy if required.
Common Challenges and Practical Solutions
Challenge: Delays in product testing due to limited availability of testing slots.
- Solution: Book testing appointments well in advance and consider multiple CDSCO-approved labs.
Challenge: Incomplete or inconsistent documentation leading to multiple queries.
- Solution: Use standardized templates for Device Master File and Plant Master File and conduct internal audits before submission.
Challenge: Scheduling of CDSCO audits can be unpredictable.
- Solution: Maintain readiness at all times and have all staff trained and available for inspections.
Challenge: Understanding specific regulatory nuances for high-risk neurological devices.
- Solution: Engage expert consultants with proven experience to navigate complex requirements.
Expert Consultation and Support
With our deep expertise in CDSCO licensing, we assist clients from initial classification to final license grant. Our support includes:
- Gap analysis and compliance roadmap
- Preparation of technical documentation including risk management and essential principles checklist
- Coordination with notified bodies and testing laboratories
- Audit readiness and mock inspections
- Liaising with CDSCO officials for smooth queries resolution
Our proven track record with over 500 companies and specific experience with Class D neurological devices ensures your application is robust and compliant.
Getting Started with Your CDSCO License Application
For manufacturers and importers of the Transvenous Phrenic Nerve Electrical Stimulation Control Unit, here are practical next steps:
- Conduct a thorough classification review to confirm Class D status.
- Initiate document preparation immediately, focusing on your Device Master File, Plant Master File, and Risk Management File.
- Apply for the Test License (MD13) if manufacturing domestically, to start product testing early.
- Book your product testing at a CDSCO-approved laboratory from the official Testing Laboratories list.
- Register and submit applications via the CDSCO MD Online Portal.
- Prepare your facility for the CDSCO audit with comprehensive documentation and trained personnel.
- Engage experienced regulatory consultants to guide you through complex processes and ensure timely compliance.
Navigating CDSCO licensing for a Class D neurological device like the Transvenous Phrenic Nerve Electrical Stimulation Control Unit is complex but manageable with the right preparation and expert support. We invite you to contact us to leverage our 25+ years of regulatory expertise and ensure your successful market entry in India.
For more detailed guides, please review our resources on the MD9 License process and Import License process.